where to be

10+ can't-miss Houston business and innovation events for April

Check out these conferences, pitch events, networking, and more happening in Houston in the month of April. Photo via Getty Images

After a very busy March, Houston innovators might need to prepare for another month of networking opportunities. Here's a rundown of what all to throw on your calendar for April.

This article will be updated as more business and tech events are announced.

April 5-6 — Energy CEO Summit

Industry leaders and members of the Houston business community will discuss the evolution of the energy sector, Houston's pivotal role, and the critical events driving the change.

Center for Houston's Future CEO Brett Perlman will moderate a panel on Electrical Grid Trends at 9:30 a.m. on Wednesday, April 6.

The event is Tuesday and Wednesday, April 5-6, online or at Asia Society Texas Center (1370 Southmore Blvd.). Click here to register.

April 6 — 2022 PVAMU Industry Innovation Collaboration Day

This event is designed to provide an interactive platform for academicians, researchers, students, industries, and government agencies an opportunity to meet and share recent innovations, developments, and technology trends. Collaboration between the university and various industries needs to be nourished to enhance innovation development for the benefit of society.

The event is Wednesday, April 6, from 8:30 am to 5 pm at Prairie View A&M University-MSC Ballroom (155 L.W Minor St.). Click here to register.

April 6 — Enventure "Inspire" Seminar Series - With Dr. Santosh A. Helekar, MD, PhD

The "Inspire" Seminar Series was developed by Enventure to help students learn about the reality of working in the biotech and biomedical fields. The series consists of a number of events starring guest speakers coming from different areas in the biotech and biomedical industries.

This particular event will star Dr. Santosh A. Helekar, M.D., Ph.D. Participants attending this event will learn about the story of Dr. Helekar and his experiences from transitioning from grad school & academia into an inventor & his experiences and current role. In addition, there will be a final Q&A where the audience will be able to ask direct questions to Dr. Helekar.

The online event is Wednesday, April 6, from 6 to 7:30 pm. Click here to register.

April 7 — Low-Carbon Hydrogen Accelerator Kickoff

Together with Greentown Labs and the Urban Future Lab, EPRI and Shell recognize the need to accelerate the development and commercialization of low-carbon technologies required to enable economy-wide decarbonization. As leaders in the utilities and energy industries, respectively, with domain expertise, R&D facilities, and access to global customers, EPRI and Shell are uniquely positioned to lead this transformation in partnership with startups innovating at the cutting edge of low-carbon hydrogen.

The hybrid event is Thursday, April 7, from 5:30 to 8 pm at Greentown Labs (4200 San Jacinto St.) and streaming online. Click here to register.

April 7-9 — 2022 Rice Business Plan Competition

The 2022 Rice Business Plan Competition will be hosted in Houston at the Jones Graduate School of Business. This year, 42 teams have been invited to compete in the 22nd Annual Competition. The finals will be streamed online —watch on Saturday, April 9 on our YouTube. If you're a member, please visit our membership page to register to attend in-person.

The competition is held Thursday through Saturday, April 7-9, at Rice University (6100 Main St.) and streamed online. Click here to register.

April 12 — Energy & Energy 2.0 Council

As the Energy Capital of the World, Houston is the headquarters and the intellectual capital for virtually every segment of the energy industry including exploration, production, transmission, marketing, supply, and technology. This Council explores how Houston's largest industry continues to lead in this critical sector while also advancing innovation that supports the transition to a more efficient and sustainable, low-carbon future that also accommodates global demand growth.

The event is Tuesday, April 12, from 11:30 am to 1 pm at Partnership Tower (701 Avenida de las Americas, Suite 900). Click here to register.

April 12 — Softeq Venture Studio Demo Day (Q1 2022 Cohort)

The Softeq Venture Studio invested $125,000 in cash and services in each of the nine early-stage startups to help them refine their business model, build their technology, and prepare them to scale. In this capstone event, founders have seven minutes each to present their pitch deck, demo their product, outline their ask, and answer questions. And we need you there to evaluate them for investment (or at least support them).

The event is Tuesday, April 12, from 5 to 7:30 pm at The Ion (4201 Main St.). Click here to register.

April 13 — Serving & Selling: Building your Brand, brought to you by Insperity

Find out how to solidify your brand, deliver exceptional service, and take your productivity to the next level, with Pete Hinojosa, CBPA.

The event is Wednesday, April 13, from 1:30 to 2:30 pm at The Cannon (1334 Brittmore Dr.). Click here to register.

April 14 — DivInc Happy Hour: Meet the Sports Tech Cohort

Meet DivInc's Sports Tech cohort at a happy hour hosted at The Ion on April 14. The companies accepted into the new cohort are slated to be announced on April 11.

The event is Thursday, April 14, at 5:30 pm at The Ion (4201 Main St.). Click here to register.

April 19 — State of Technology

The second annual Greater Houston Partnership event features business leaders discussing Houston's growth as a national leader in tech innovation and the many qualities the region possesses that support a robust tech ecosystem. Through a panel discussion, the event will also explore how Houston is uniquely enabling digital transformation across industries including energy, life sciences and healthcare, manufacturing, logistics, and aerospace.

The event is Tuesday, April 19, at 10 am to 1:30 pm at Hilton Americas (1600 Lamar St.). Click here to register.

April 20 — Spring 2022 D2K Showcase

Explore Rice University's D2K students’ end-of-semester projects covering a wide range of topics including computer vision, natural language processing, deep learning applications, web scraping, time series analysis, signal processing and more. Celebrate the impact they are making through data science and interact with Rice students and learn more about their projects in the poster session. Attendees can vote for their favorite project/team to compete for cash prizes.

The event is Wednesday, April 20, from 5 to 7 pm at Duncan Hall at Rice University (6100 Main St.). Click here to register.

April 20 — The H. Albert Napier Rice Launch Challenge Championships

Join Liu Idea Lab for Innovation and Entrepreneurship and support Rice University student startups at the H. Albert Napier Rice Launch Challenge Championships on Wednesday, April 20. Six student finalists will pitch their ventures for the chance to win a share of $75,000+ in equity-free funding. Attendance is open to Rice students, Rice alumni, friends of Rice, and the whole Houston entrepreneurial community. Seats are limited, so get your tickets while you still can.

The event is Wednesday, April 20, from 5:30 to 9 pm at The Anderson-Clarke Center’s Hudspeth Auditorium (6100 Main St.). Click here to register.

April 21 — Greentown Houston's First Anniversary

A year after opening the Houston's first-ever climatetech startup incubator, Greentown Houston is home to over 60 startup members and 20 corporate partners. Join the green tech hub for a celebration of entrepreneurship, collaboration, and innovation, which together with the engineering strength and talent of the region’s energy industry will power Houston’s climate leadership. The day of festivities will include celebratory remarks, lightning pitches from some of our outstanding startups, a member showcase, networking, and more.

The event is Thursday, April 21, from 1 to 7 pm, at Greentown Houston (4200 San Jacinto St.) or livestreaming online. Click here to register.

April 27 — Engage VC: Revolution

Revolution is a D.C.-based investment firm focused on investing in entrepreneurs building transformative companies outside of Silicon Valley. With $1.7 billion of capital commitments across portfolio companies including Houston-based Goodfair and relationships in 60+ startup communities, Revolution is dedicated to creating meaningful results for companies outside of the Bay Area. And they are coming to Houston. Join HX Venture Fund to hear Tige Savage, Co-Founder & Managing Partner at Revolution Ventures, David Hall, Managing Partner at Revolution's Rise of the Rest Seed Fund, and Martin Simoncic, President B2B at PROS discuss Revolution's perspective on venture investing, current and future trends, and how Houston fits in among other topics.

The event is Wednesday, April 27, at 8:30 to 10 am at The Ion (4201 Main St.). Click here to register.


Trending News

Building Houston

 
 

The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

Trending News